Literature DB >> 2830335

Plasma membrane-associated tumor necrosis factor. A non-integral membrane protein possibly bound to its own receptor.

O Bakouche1, Y Ichinose, R Heicappell, I J Fidler, L B Lachman.   

Abstract

Purified plasma membranes from LPS-activated human blood monocytes produced significant lysis and growth inhibition of the TNF-sensitive L929 murine fibroblast cell line. Unactivated human monocyte plasma membranes did not display either activity. Anti-TNF serum specifically inhibited the anti-tumor activity of activated monocyte membranes whereas anti-IL-1 serum or non-specific rabbit serum decreased neither the lysis nor growth inhibition of L929 cells. Membrane-associated TNF did not behave as an integral protein as it could be eluted from the plasma membranes by either high salt or low pH treatment. Plasma membranes cleared of membrane-associated TNF by high salt treatment were able to bind TNF, and this binding was specifically inhibited by preincubation of rTNF with specific anti-TNF serum. Western blot analysis of plasma membranes showed a membrane-associated TNF with a m. w. of approximately 17 kDa present only in the activated monocytes. When the plasma membranes were preincubated with the cross-linker agent dissuccinimidyl suberate, Western blot analysis revealed the presence of a TNF-binding protein with a Mr of approximately 102 kDa. These studies indicate that unlike IL-1, membrane-associated TNF is not an integral membrane protein and that TNF may be associated with the monocyte membrane by occupying the TNF R.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2830335

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Tumor necrosis factor: an update on basic research and clinical applications.

Authors:  M Schleuning; R Munker
Journal:  Klin Wochenschr       Date:  1990-09-03

2.  Mouse macrophage clones immortalized by retroviruses are functionally heterogeneous.

Authors:  L Pirami; B Stockinger; S B Corradin; M Sironi; M Sassano; P Valsasnini; M Righi; P Ricciardi-Castagnoli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Effect of mycoplasmas on natural cytotoxic activity and release of tumor necrosis factor alpha by spleen cells.

Authors:  Y Lin; J L Collins; P G Case; P Q Patek
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.

Authors:  F T Stevenson; S L Bursten; R M Locksley; D H Lovett
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

5.  Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.

Authors:  C Zuany-Amorim; S Hailé; D Leduc; C Dumarey; M Huerre; B B Vargaftig; M Pretolani
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Tumor cytotoxicity of human monocyte membrane-bound interleukin-1 alpha induced by synergistic actions of interferon-gamma and synthetic acyltripeptide, FK-565.

Authors:  N Inamura; S Sone; A Okubo; E Kunishige; M Nakanishi; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Natural cytotoxic activity is not necessarily mediated by the release of tumour necrosis factor.

Authors:  P Q Patek; Y Lin
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

8.  Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages.

Authors:  S W Chensue; D G Remick; C Shmyr-Forsch; T F Beals; S L Kunkel
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

9.  The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat liver after treatment with lipopolysaccharide.

Authors:  T Nagano; T Kita; N Tanaka
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

10.  Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.

Authors:  A M Pullyblank; P J Guillou; J R Monson
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.